In person ZoBio attended the 9th RSC-BMCS Fragment-based Drug Discovery meeting in Cambridge. The meeting focused on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs. ZoBio was represented by Pim de Vink (Scientist, Assay Development and Screening) who presented poster Screening for Fragment Molecular…
31th Protein Structure Determination in Industry meeting
In person Starting from Sunday October 12th the ZoBio team participated in the 31th Protein Structure Determination in Industry meeting, which was held at the Wellcome Genome Campus, Hinxton Cambridge. This year’s meeting was organized jointly by the EMBL-EBI and GSK, supported by Hg3 Conferences. The scientific talks clustered around the following major themes: Our scientists:…
Discovery on Target
In person Our team participated in Discovery on Target, the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. The conference highlighted advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small…
SCI / RSC 22nd Medicinal Chemistry Symposium
In person From 10 to 13 September the ZoBio team participated in SCI/RSC 22nd Medicinal Symposium in Cambridge. This symposium, is Europe’s premier biennial Medicinal Chemistry event, focusing on first disclosures and new strategies in Medicinal Chemistry. ZoBio was represented by Denise Tsagris, Henri van Son and Kasia Borsuk. It was a great opportunity to…